Would you travel internationally without a reference guide? Probably not, and you shouldn’t do business without one either. This edition of Pharma Reports provides pharmaceutical executives with an insider’s look at the developments and trends shaping the Brazilian pharmaceutical industry.
As the world’s sixth largest pharma market — scheduled to rise to fifth in the near future — Brazil is becoming increasingly important in the strategies of healthcare and life science companies with truly global ambitions. But how will the Brazilian market evolve as it exits a two-year recession period that ended in 2017?
This exclusive report includes in-depth interviews with KOLs, CEOs, government officials, and regulators to examine this question and other issues such as:
Data related to Brazil’s economic growth, pharma market, and healthcare landscape
- Opportunities identified by representatives of key global players within the Brazilian pharma industry
- Regulatory upgrades and shifts in governmental priorities
- Strategies and successes of domestic pharma companies
- Briefings from across the value chain in areas that include logistics, plastic surgery, and homeopathy